(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SYNTACOLL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SYNTACOLL

ST13

US500000090510256

Class

5, 10, 40, 42

Filing

90510256

Registration

6663335

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

11/08/2023

Trademark type

Word

Nice classes

5, 10, 40, 42

Filing date

02/04/2021

Registration date

03/08/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/08/2022

Last transaction

03/08/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Athlone, Co. Roscommon, IE

Examiner

COHEN, ROBERT ANDREW

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Innocoll Pharmaceuticals Limited

Representatives

Camille M. Miller COZEN O'CONNOR

Technical classification

Nice Classes

Class 5Class 10Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticalveterinary and sanitary preparationsin particular preparations containing collagen for treating wounds and burns; surgical implants comprising living tissue for wound healing and hemostatic purposesexcept dental implants

Class 10

Implants consisting primarily of artificial materials for wound healing and hemostatic useexcept dental implants

Class 40

manufacturing pharmaceutical products for others; custom synthesis of collagen-based absorbable implants and wound dressings to the order and specification of others; custom manufacturing and processing servicesmanufacturing and processing of collagen-based absorbable implants and wound dressings to the specification of others

Class 42

Scientific research in the fields of collagenchemicals and pharmaceuticals; product safety testing in the fields of collagenchemicals and pharmaceuticals; research and development of new products for others in the fields of collagenchemicals and pharmaceuticals; Genotyping services for research or analysis related to genomic discoveries in the pharmaceuticalinformatics and clinical diagnostic industries; Gene-sequencing-based tests for research purposes; Design and development for others of collagen-based absorbable implants and wound dressings and methods for drug discovery; scientific researchdevelopment of pharmaceuticals and diagnostic methods for others

Publications

History of USPTO decisions and trademark events.

16 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

11/08/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

03/08/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/21/2021

PUBO

PUBLISHED FOR OPPOSITION

12/21/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/01/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/11/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/14/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/14/2021

ALIE

ASSIGNED TO LIE

10/13/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/06/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/02/2021

GNRT

NON-FINAL ACTION E-MAILED

09/02/2021

CNRT

NON-FINAL ACTION WRITTEN

09/02/2021

DOCK

ASSIGNED TO EXAMINER

08/27/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/08/2021

NWAP

NEW APPLICATION ENTERED

02/08/2021

Continuous trademark protection

Get notified about every new filing that threatens SYNTACOLL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.